Mar 03, 2013The large amount of counterfeit drugs appearing in developing nations, as well as the exponentially rising emergence of fraudulent medicine in those countries, has motivated research into integrating advanced RFID instruments into the pharmaceutical industry. Eldar Sultanow, the CIO of XQS Service GmbH, discusses such research—which is working toward identifying and preventing counterfeit drugs from appearing on the market, and preserving the quality and security of pharmaceutical products—and outlines a comprehensive and safer model for medical lifecycles, utilizing radio frequency identification. (15 pages)
Controlling Fraudulent and Quality-Impaired Medicine: An Awareness Model
SEND IT YOUR WAY
ASK THE EXPERTS
ASK A QUESTION FOR OUR EXPERTS
ASK THE EXPERTS
View previous question answers »